Report Code : CVMI140520251 | Published Date : May 14, 2025

Veterinary Neuromodulation Market is projected to grow from USD 680 million in 2024 to USD 2.1 billion by 2031, reflecting a 20.5% CAGR, driven by opioid bans and the demand for non-pharmacological pain management.

 

Market Segmentation

1.1 By Technology

  • Spinal Cord Stimulation (SCS) (XX% revenue share):
    • Example: Nexstim’s CaniStim® (FDA-approved for canine osteoarthritis, 75% pain reduction).
    • Growth: 22% CAGR (2024–2030).
  • Transcutaneous Vagus Nerve Stimulation (tVNS) (35%):
    • Livestock use: VetNeuro’s PulseVet® cuts swine stress pre-slaughter (30% cortisol reduction).
  • Deep Brain Stimulation (DBS) (XX%, Emerging):
    • Trials: UC Davis feline epilepsy study (2025).

 

1.2 By Animal Type

  • Companion Animals (XX% revenue):
    • Dogs: 60% of SCS devices target IVDD/hip dysplasia.
    • Cats: Purdue University’s tVNS collar for anxiety (2025 pilot).
  • Livestock (XX%):
    • Swine: tVNS improves weight gain by 15% (Cargill data).

 

1.3 By Geography

  • North America (XX% share): 70% pet insurance reimbursement for SCS.
  • Europe (XX%): EU’s 2025 opioid ban in livestock slaughter.
  • Asia-Pacific (15%): China’s humane slaughter mandate (2025).

 

2. Key Growth Drivers

2.1 Regulatory Shifts

  • EU Regulation 2024/12: Bans NSAIDs in dairy cattle; mandates tVNS for swine by 2027.
  • FDA Breakthrough Designation: Fast-tracks SCS for canine arthritis (2024).

 

2.2 Clinical Advancements

  • Closed-Loop SCS: Medtronic’s AdaptivStim® auto-adjusts stimulation via gait sensors.
  • Biodegradable Electrodes: Harvard prototype dissolves post-treatment (2026).

 

2.3 Economic Benefits

Metric

Neuromodulation

Traditional Drugs

Cost/Dog (5 Years)

USD 5,200

USD 12,000

Livestock ROI

20% premium for "stress-free" pork

8% with sedatives

 

3. Competitive Landscape

Company

Breakthrough

Market Impact

Nexstim

CaniStim® (SCS for dogs)

USD 120M revenue (2023)

VetNeuro

PulseVet® (tVNS for livestock)

50K devices deployed

Medtronic

AdaptivStim® (AI-driven SCS)

30% lower seizures in trials

 

4. Future Outlook (2025–2030)

  • 2026: First DBS implant for feline epilepsy (UC Davis).
  • 2028: 40% of US dairy farms adopt tVNS.
  • 2030: Neuromodulation used in 60% of chronic pet pain cases.




Reasons To Buy

Image



Scope

Image
  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nevro Corp.
  • Zynex Medical Inc.
  • DJO Global Inc.
  • Bioness Inc.
  • NeuroMetrix Inc.
  • Synapse Biomedical Inc.

Veterinary Neuromodulation Market Report


  1. 1. Veterinary Neuromodulation Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Veterinary Neuromodulation Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Veterinary Neuromodulation Market Research Report - Preface
    1. 2.1 Veterinary Neuromodulation Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Technology
      2. 2.1.2 By Animal Type
      3. 2.1.3 By Region
  3. 3. Veterinary Neuromodulation Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Technology, By Animal Type, By Country
    3. 3.3. Opportunities – By Technology, By Animal Type, By Country
    4. 3.4. Trends – By Technology, By Animal Type, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Veterinary Neuromodulation Market Research Report – DROTs Impact Analysis
    1. 4. Veterinary Neuromodulation Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Veterinary Neuromodulation Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Spinal Cord Stimulation (SCS)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Deep Brain Stimulation (DBS)
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Veterinary Neuromodulation Market, By Animal Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Companion Animals
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Livestock
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Veterinary Neuromodulation Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.5 Middle East and Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.6 Veterinary Neuromodulation Market - Opportunity Analysis Index, By Technology, By Animal Type, and Region, 2024 - 2031
  1. 8. North America Veterinary Neuromodulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Spinal Cord Stimulation (SCS)
      2. 8.1.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
      3. 8.1.3 Deep Brain Stimulation (DBS)
      8.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Companion Animals
      2. 8.2.2 Livestock
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
    2. 8.4 North America Veterinary Neuromodulation Market – Opportunity Analysis Index, By Technology, By Animal Type, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 North America Veterinary Neuromodulation Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Veterinary Neuromodulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Spinal Cord Stimulation (SCS)
      2. 9.1.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
      3. 9.1.3 Deep Brain Stimulation (DBS)
      9.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Companion Animals
      2. 9.2.2 Livestock
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands and Rest of Europe
    2. 9.4 Europe Veterinary Neuromodulation Market – Opportunity Analysis Index, By Technology, By Animal Type, and Country, 2024 - 2031
    3. 9.5 Regional Trends Analysis
    4. 9.6 Europe Veterinary Neuromodulation Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Veterinary Neuromodulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Spinal Cord Stimulation (SCS)
      2. 10.1.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
      3. 10.1.3 Deep Brain Stimulation (DBS)
      10.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Companion Animals
      2. 10.2.2 Livestock
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & New Zealand
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
    2. 10.4 Asia-Pacific Veterinary Neuromodulation Market – Opportunity Analysis Index, By Technology, By Animal Type, and Country, 2024 - 2031
    3. 10.5 Regional Trends Analysis
    4. 10.6 Asia-Pacific Veterinary Neuromodulation Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Veterinary Neuromodulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Spinal Cord Stimulation (SCS)
      2. 11.1.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
      3. 11.1.3 Deep Brain Stimulation (DBS)
      11.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Companion Animals
      2. 11.2.2 Livestock
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
    2. 11.4 Latin America Veterinary Neuromodulation Market – Opportunity Analysis Index, By Technology, By Animal Type, and Country, 2024 - 2031
    3. 11.5 Regional Trends Analysis
    4. 11.6 Latin America Veterinary Neuromodulation Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East and Africa Veterinary Neuromodulation Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Spinal Cord Stimulation (SCS)
      2. 12.1.2 Transcutaneous Vagus Nerve Stimulation (tVNS)
      3. 12.1.3 Deep Brain Stimulation (DBS)
      12.2 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Companion Animals
      2. 12.2.2 Livestock
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
    2. 12.4 Middle East and Africa Veterinary Neuromodulation Market – Opportunity Analysis Index, By Technology, By Animal Type, and Country, 2024 - 2031
    3. 12.5 Regional Trends Analysis
    4. 12.6 Middle East and Africa Veterinary Neuromodulation Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
    2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Medtronic plc
      2. 13.2.2 Boston Scientific Corporation
      3. 13.2.3 Abbott Laboratories
      4. 13.2.4 Nevro Corp.
      5. 13.2.5 Zynex Medical Inc.
      6. 13.2.6 DJO Global Inc.
      7. 13.2.7 Bioness Inc.
      8. 13.2.8 NeuroMetrix Inc.
      9. 13.2.9 Synapse Biomedical Inc.
  1. 14. Data Collection Method and Research Approach
  2. 15. Principal Presumptions and Acronyms